Key result
COX-2-specific inhibitors are efficacious in inflammatory conditions but have potential safety concerns that raise questions about their benefit/risk ratio compared to conventional NSAIDs.
Why the study?
Do COX-2-specific inhibitors have a better efficacy and safety profile compared to conventional NSAIDs?
Do COX-2-specific inhibitors have a better efficacy and safety profile compared to conventional NSAIDs?
This review highlights that despite their efficacy, COX-2-specific inhibitors have potential safety concerns compared to conventional NSAIDs.
Answers are grounded in this paper and cite their sources.
Questions net benefit of COX-2 inhibitors over NSAIDs; leaves open need for head-to-head trials to clarify risk-benefit.
The discovery of two isoforms of the cyclooxygenase enzyme, COX-1 and COX-2, and the development of COX-2-specific inhibitors as anti-inflammatories and analgesics have offered great promise that the therapeutic benefits of NSAIDs could be optimized through inhibition of COX-2, while minimizing their adverse side effect profile associated with inhibition of COX-1. While COX-2 specific inhibitors have proven to be efficacious in a variety of inflammatory conditions, exposure of large numbers of patients to these drugs in postmarketing studies have uncovered potential safety concerns that raise questions about the benefit/risk ratio of COX-2-specific NSAIDs compared to conventional NSAIDs. This article reviews the efficacy and safety profiles of COX-2-specific inhibitors, comparing them with conventional NSDAIDs.
No takes yet. Share an insight, caveat, or question.
Mengle-Gaw et al. (2002) conducted a review in Inflammatory conditions. COX-2-specific inhibitors vs. Conventional NSAIDs was evaluated on Efficacy and safety profiles. COX-2-specific inhibitors are efficacious in inflammatory conditions but have potential safety concerns that raise questions about their benefit/risk ratio compared to conventional NSAIDs.
Synapse has enriched 10 related papers. Consider them for comparative context: